Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement
The merger will create a publicly traded company focused on advancing Caldera's lead inflammatory bowel disease therapy, with financing expected to fund operations into 2029. Synlogic (USOTC:SYBX) ag
Yahoo Finance — 29 July 2026
Text:
24
0
0
The merger will create a publicly traded company focused on advancing Caldera's lead inflammatory bowel disease therapy, with financing expected to fu
Read Full Story at Yahoo Finance → Sources
📈 Markets & Finance
Trump finalizes new tariffs on dozens of countries
📈 Markets & Finance
Little Movement Seen For Thai Stock Market
📈 Markets & Finance
Higher Open Called For Indonesia Stock Market
📈 Markets & Finance
Ethereum Foundation adds SEAL 911 co-founder to board as privacy focus grows
📈 Markets & Finance
BlackRock, Coinbase and Strategy Pledge $15M to Quantum-Proof Bitcoin
📈 Markets & Finance
Investors withdraw $475 million from American Bitcoin ETFs, market confidence falters.
